MCID: SKN006
MIFTS: 41

Skin Sarcoidosis

Categories: Immune diseases, Skin diseases

Aliases & Classifications for Skin Sarcoidosis

MalaCards integrated aliases for Skin Sarcoidosis:

Name: Skin Sarcoidosis 12 15 17
Cutaneous Sarcoidosis 12 74
Cutaneous Sarcoid 12

Classifications:



External Ids:

Disease Ontology 12 DOID:13402
NCIt 51 C34996
SNOMED-CT 69 55941000
ICD10 34 D86.3
UMLS 74 C0036203

Summaries for Skin Sarcoidosis

MalaCards based summary : Skin Sarcoidosis, also known as cutaneous sarcoidosis, is related to sarcoidosis 1 and vasculitis. An important gene associated with Skin Sarcoidosis is ACE (Angiotensin I Converting Enzyme), and among its related pathways/superpathways are NF-kappaB Signaling and Amyotrophic lateral sclerosis (ALS). The drugs Apremilast and Hormone Antagonists have been mentioned in the context of this disorder. Affiliated tissues include skin, thyroid and heart, and related phenotype is liver/biliary system.

Related Diseases for Skin Sarcoidosis

Diseases related to Skin Sarcoidosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 122)
# Related Disease Score Top Affiliating Genes
1 sarcoidosis 1 29.8 ACE TNF TNFRSF1B
2 vasculitis 29.4 TNF TNFRSF1B
3 blau syndrome 11.2
4 bladder neck obstruction 10.2 ACE TNFRSF1B
5 uveoparotid fever 10.2 ACE TNF
6 subacute cutaneous lupus erythematosus 10.2 ACE TNF
7 hepatitis 10.2
8 posterior urethral valves 10.2 ACE TNF
9 ischemic heart disease 10.2 ACE TNF
10 juvenile ankylosing spondylitis 10.1 TNF TNFRSF1B
11 spondylitis 10.1 TNF TNFRSF1B
12 chronic gonococcal salpingitis 10.1 TNF TNFRSF1B
13 scleral disease 10.1 TNF TNFRSF1B
14 hepatitis c 10.1
15 pustulosis of palm and sole 10.1 TNF TNFRSF1B
16 peroneal neuropathy 10.1 TNF TNFRSF1B
17 extrinsic cardiomyopathy 10.1 ACE TNF
18 periodic fever, familial, autosomal dominant 10.1 TNF TNFRSF1B
19 rheumatic heart disease 10.1 ACE TNF
20 acute salpingitis 10.1 TNF TNFRSF1B
21 post-transplant lymphoproliferative disease 10.1 TNF TNFRSF1B
22 pyelonephritis 10.1 ACE TNF
23 chronic salpingitis 10.1 TNF TNFRSF1B
24 limb ischemia 10.1 ACE TNF
25 exanthem 10.1 TNF TNFRSF1B
26 panuveitis 10.1 TNF TNFRSF1B
27 silicosis 10.1 ACE TNF
28 cogan syndrome 10.1 TNF TNFRSF1B
29 carotid stenosis 10.1 ACE TNF
30 palindromic rheumatism 10.1 TNF TNFRSF1B
31 adult respiratory distress syndrome 10.1 ACE TNF
32 pulmonary sarcoidosis 10.1 ACE TNF
33 uveal disease 10.1 TNF TNFRSF1B
34 pulmonary edema 10.1 ACE TNF
35 guillain-barre syndrome 10.1 TNF TNFRSF1B
36 sleep apnea 10.1 ACE TNF
37 rasmussen encephalitis 10.1 ADK TNF
38 end stage renal failure 10.1 ACE TNF
39 spondyloarthropathy 1 10.1 TNF TNFRSF1B
40 primary bacterial infectious disease 10.1 TNF TNFRSF1B
41 vascular dementia 10.1 ACE TNF
42 bone inflammation disease 10.1 TNF TNFRSF1B
43 arteries, anomalies of 10.0 ACE TNF
44 autoimmune disease of peripheral nervous system 10.0 CD1E TNF
45 glucose metabolism disease 10.0 ACE TNF
46 juvenile rheumatoid arthritis 10.0 TNF TNFRSF1B
47 membranous nephropathy 10.0 ACE TNF
48 chagas disease 10.0 ACE TNF
49 melanoma 10.0
50 hansen's disease 10.0

Graphical network of the top 20 diseases related to Skin Sarcoidosis:



Diseases related to Skin Sarcoidosis

Symptoms & Phenotypes for Skin Sarcoidosis

MGI Mouse Phenotypes related to Skin Sarcoidosis:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 liver/biliary system MP:0005370 8.92 ACE ADK TNF TNFRSF1B

Drugs & Therapeutics for Skin Sarcoidosis

Drugs for Skin Sarcoidosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 49)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Apremilast Approved, Investigational Phase 2, Phase 3 608141-41-9 11561674
2 Hormone Antagonists Phase 2, Phase 3
3 Neurotransmitter Agents Phase 2, Phase 3
4 beta-endorphin Phase 2, Phase 3
5 Adrenocorticotropic Hormone Phase 2, Phase 3
6 Endorphins Phase 2, Phase 3
7 Hormones Phase 2, Phase 3
8 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3
9 Melanocyte-Stimulating Hormones Phase 2, Phase 3
10 Angiogenesis Modulating Agents Phase 2, Phase 3,Phase 3
11 Immunosuppressive Agents Phase 2, Phase 3,Phase 3
12 Analgesics Phase 2, Phase 3
13 Immunologic Factors Phase 2, Phase 3,Phase 3
14 Anti-Inflammatory Agents Phase 2, Phase 3
15 Analgesics, Non-Narcotic Phase 2, Phase 3
16 Angiogenesis Inhibitors Phase 2, Phase 3,Phase 3
17 Peripheral Nervous System Agents Phase 2, Phase 3
18 Anti-Bacterial Agents Phase 2, Phase 3,Phase 3,Phase 1
19 Anti-Inflammatory Agents, Non-Steroidal Phase 2, Phase 3
20 Anti-Infective Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
21 Antirheumatic Agents Phase 2, Phase 3
22
Adalimumab Approved Phase 2 331731-18-1 16219006
23
Levofloxacin Approved, Investigational Phase 1, Phase 2 100986-85-4 149096
24
Azithromycin Approved Phase 1, Phase 2 83905-01-5 447043 55185
25
Ofloxacin Approved Phase 1, Phase 2 82419-36-1 4583
26
Ethambutol Approved Phase 1, Phase 2 74-55-5 14052 3279
27
Rifampicin Approved Phase 1, Phase 2 13292-46-1 5381226 5458213
28
Ustekinumab Approved, Investigational Phase 2 815610-63-0
29 Cytochrome P-450 Enzyme Inhibitors Phase 1, Phase 2
30 Anti-Infective Agents, Urinary Phase 1, Phase 2
31 Antibiotics, Antitubercular Phase 1, Phase 2
32 Nucleic Acid Synthesis Inhibitors Phase 1, Phase 2
33 Cytochrome P-450 CYP1A2 Inhibitors Phase 1, Phase 2
34 Antitubercular Agents Phase 1, Phase 2
35 Renal Agents Phase 1, Phase 2
36 Topoisomerase Inhibitors Phase 1, Phase 2
37 Cytochrome P-450 CYP3A Inducers Phase 1, Phase 2
38 Dermatologic Agents Phase 2
39 Immunoglobulins Phase 2
40 Antibodies Phase 2
41 Antibodies, Monoclonal Phase 2
42
Tofacitinib Approved, Investigational Not Applicable 477600-75-2
43
Maraviroc Approved, Investigational Not Applicable 376348-65-1 3002977
44 Protein Kinase Inhibitors Not Applicable
45 Pharmaceutical Solutions Not Applicable
46 Anesthetics Not Applicable
47 Anti-HIV Agents Not Applicable
48 Anti-Retroviral Agents Not Applicable
49 Antiviral Agents Not Applicable

Interventional clinical trials:

(show all 11)
# Name Status NCT ID Phase Drugs
1 ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial Unknown status NCT02348905 Phase 2, Phase 3 ACTHAR Gel 40 units twice weekly;ACTHAR Gel 80 units twice weekly.
2 The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis Completed NCT00794274 Phase 2, Phase 3 CC-100004
3 SARCOTHAL. Thalidomide in Skin Sarcoidosis Completed NCT00305552 Phase 3 THALIDOMIDE
4 A Study of Adalimumab to Treat Sarcoidosis of the Skin Completed NCT00274352 Phase 2 adalimumab
5 Trial of Antimycobacterial Therapy in Sarcoidosis Completed NCT01074554 Phase 1, Phase 2 Antibiotic Regimen;Placebo Regimen
6 A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis Completed NCT00955279 Phase 2 Placebo;Golimumab;Ustekinumab
7 A Phase 2 Study With CC-220 in Skin Sarcoidosis Withdrawn NCT02192489 Phase 2 CC-220 0.3 mg Daily;CC-220 0.6mg Daily;Placebo
8 Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis Withdrawn NCT00731757 Phase 2 Humira
9 Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis Withdrawn NCT00690911 Phase 2 adalimumab
10 Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare Recruiting NCT03910543 Not Applicable Tofacitinib 5 mg twice daily
11 Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes Terminated NCT02134717 Not Applicable all subjects will receive maraviroc 300mg orally twice a day for 6 weeks

Search NIH Clinical Center for Skin Sarcoidosis

Genetic Tests for Skin Sarcoidosis

Anatomical Context for Skin Sarcoidosis

MalaCards organs/tissues related to Skin Sarcoidosis:

42
Skin, Thyroid, Heart, T Cells, Bone, Myeloid

Publications for Skin Sarcoidosis

Articles related to Skin Sarcoidosis:

(show top 50) (show all 296)
# Title Authors Year
1
Cutaneous sarcoidosis after Hodgkin lymphoma. ( 30411336 )
2019
2
Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera. ( 31008168 )
2019
3
Biologic Therapy in the Treatment of Cutaneous Sarcoidosis: A Literature Review. ( 30895525 )
2019
4
Foreign-Body Granulomata Caused by Injected Permanent Filler Masquerading as Cutaneous Sarcoidosis. ( 30921058 )
2019
5
New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review. ( 31019572 )
2019
6
Natalizumab induced cutaneous sarcoidosis-like reaction. ( 31108403 )
2019
7
The natural history of cutaneous sarcoidosis. Clinical spectrum and histological analysis of 40 cases. ( 30306543 )
2019
8
Heerfordt syndrome developing in a patient with cutaneous sarcoidosis. ( 30623412 )
2019
9
In-vivo assessment of a case of cutaneous sarcoidosis using reflectance confocal microscopy. ( 30726472 )
2019
10
Physicochemical characterization of inorganic deposits associated with granulomas in cutaneous sarcoidosis. ( 29972866 )
2019
11
Cardiac involvement in cutaneous sarcoidosis. ( 26376041 )
2019
12
Management of skin sarcoidosis with minocycline monotherapy. ( 30911395 )
2019
13
Polymorphous Cutaneous Sarcoidosis Associated with Peripheral Vascular Disease and its Dermatoscopic Findings. ( 30050815 )
2018
14
Exploring the dynamic changes between pulmonary and cutaneous sarcoidosis based on gene expression. ( 30403187 )
2018
15
Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis. ( 30586518 )
2018
16
Oral Fumaderm® to treat cutaneous sarcoidosis. ( 29756252 )
2018
17
Cutaneous sarcoidosis: a new subset in the spectrum of paraneoplastic dermatoses. ( 29779211 )
2018
18
Dermoscopy of a single plaque on the face: an uncommon presentation of cutaneous sarcoidosis. ( 30116658 )
2018
19
Concurrent Diagnoses of Cutaneous Sarcoidosis and Recurrent Metastatic Breast Cancer: More than a Coincidental Occurrence? ( 30254768 )
2018
20
Micropapular Cutaneous Sarcoidosis Reviewed. ( 30278434 )
2018
21
Light and Laser Modalities in the Treatment of Cutaneous Sarcoidosis: A Systematic Review. ( 29242948 )
2018
22
Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab. ( 29500868 )
2018
23
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: an uncommon adverse effect? ( 29165307 )
2017
24
A granulomatous conundrum: Concurrent necrobiosis lipoidica, cutaneous sarcoidosis and erythema nodosum in a nondiabetic patient. ( 28211041 )
2017
25
Narrow-band UVB for pretibial (necrobiosis lipoidica-like) involvement of cutaneous sarcoidosis: a promising therapeutic option. ( 28681723 )
2017
26
Cutaneous sarcoidosis and secondary open-angle glaucoma in a patient: case report and literature review. ( 29186261 )
2017
27
Recalcitrant Diffuse Cutaneous Sarcoidosis With Perianal Involvement Responding to Adalimumab. ( 29240869 )
2017
28
Cutaneous sarcoidosis: A retrospective case series and a hospital-based case-control study in Taiwan. ( 28984765 )
2017
29
Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma. ( 28443311 )
2017
30
Koebnerization phenomenon after broadband light therapy in a patient with cutaneous sarcoidosis. ( 28752117 )
2017
31
A case of hyaluronic acid injections triggering cutaneous sarcoidosis at previously treated sites. ( 27357733 )
2017
32
High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosis. ( 29628755 )
2017
33
An Adolescent with Extensive Cutaneous Sarcoidosis without Lung Involvement. ( 28213883 )
2017
34
Cutaneous sarcoidosis. ( 28598873 )
2017
35
Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases. ( 28564695 )
2017
36
Unconventional use of fractional ablative CO2 laser in facial cutaneous sarcoïdosis. ( 29082596 )
2017
37
Annular cutaneous sarcoidosis with systemic involvement. ( 29417028 )
2017
38
Quantification of granuloma volume and response to treatment in cutaneous sarcoidosis using 3-dimensional high-frequency ultrasound scan. ( 29264382 )
2017
39
Annular lesions of cutaneous sarcoidosis with granulomatous vasculitis. ( 28116823 )
2017
40
Cutaneous sarcoidosis and macular amyloidosis occurring at the same site. ( 27297271 )
2016
41
Cutaneous sarcoidosis masquerading as chronic cutaneous lupus erythematosus - case report. ( 27646659 )
2016
42
Erythematous patches and pretibial ulcers: an uncommon presentation of cutaneous sarcoidosis. ( 26972195 )
2016
43
Resolution of Cutaneous Sarcoidosis Following Topical Application of Ganoderma lucidum (Reishi Mushroom). ( 26868374 )
2016
44
Is it a sarcoidal foreign-body granuloma or a cutaneous sarcoidosis on a permanent eyebrow make-up? ( 26073118 )
2016
45
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. ( 26847095 )
2016
46
Cutaneous sarcoidosis at insulin injection sites. ( 26783329 )
2016
47
Isolated Cutaneous Sarcoidosis. ( 26552871 )
2016
48
Cutaneous Sarcoidosis Misdiagnosed as Leprosy. Report of Two Cases and Review of Literature. ( 30207442 )
2016
49
Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy. ( 27357143 )
2016
50
Cutaneous sarcoidosis with zosteriform distribution and pulmonary involvement. ( 27176087 )
2016

Variations for Skin Sarcoidosis

Expression for Skin Sarcoidosis

Search GEO for disease gene expression data for Skin Sarcoidosis.

Pathways for Skin Sarcoidosis

GO Terms for Skin Sarcoidosis

Cellular components related to Skin Sarcoidosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.8 ACE CD83 TNF

Biological processes related to Skin Sarcoidosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.54 CD1E TNF TNFRSF1B
2 tumor necrosis factor-mediated signaling pathway GO:0033209 9.32 TNF TNFRSF1B
3 humoral immune response GO:0006959 9.26 CD83 TNF
4 intrinsic apoptotic signaling pathway in response to DNA damage GO:0008630 9.16 TNF TNFRSF1B
5 extrinsic apoptotic signaling pathway GO:0097191 8.96 TNF TNFRSF1B
6 positive regulation of membrane protein ectodomain proteolysis GO:0051044 8.62 TNF TNFRSF1B

Sources for Skin Sarcoidosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....